https://danusertibinhibitor.co....m/usage-of-segmental
The clinical trial, identified by the number NCT05045248, was conducted at the American University of Beirut Medical Center. Two drops of apraclonidine 0.5% solution were used to treat the most affected eye of patients whose ptosis was a result of myasthenia gravis. Prior to medication administration, and at 1, 5, 30, and 60 minutes post-administration, we assessed palpebral fi
إعجاب
علق
شارك
